Journals / E Journal of Cardiovascular Medicine / 2018 / Cilt: 6 - Sayı: 2

Hybrid Treatment of Supravalvular Aortic Stenosis and Coronary Ostial Stenosis in Familial Hypercholesterolemia

Pages
68–71
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

We present a 22-year-old male patient with familial hypercholesterolemia and concomitant supravalvular aortic stenosis and coronary artery disease treated with hybrid coronary revascularization approach.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Familial hypercholesterolemia (FH) is an autosomal dominant inherited metabolic disorder characterized with high levels of low-density lipoprotein (LDL) plasma cholesterol.
📊
Key Findings & Data:Increased plasma LDL-cholesterol levels cause cutaneous and tendinous xanthomas, supravalvular aortic stenosis and coronary ostial stenosis in younger ages.
💡
Conclusion & Impact:We present a 22-year-old male patient with familial hypercholesterolemia and concomitant supravalvular aortic stenosis and coronary artery disease treated with hybrid coronary revascularization approach.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Özet

Familial hypercholesterolemia (FH) is an autosomal dominant inherited metabolic disorder characterized with high levels of low-density lipoprotein (LDL) plasma cholesterol. Increased plasma LDL-cholesterol levels cause cutaneous and tendinous xanthomas, supravalvular aortic stenosis and coronary ostial stenosis in younger ages. Complications can be fatal if it is not diagnosed and treated in preliminary stages. We present a 22-year-old male patient with familial hypercholesterolemia and concomitant supravalvular aortic stenosis and coronary artery disease treated with hybrid coronary revascularization approach.

🔖

Cite This Article

SELÇUK, İ., UĞUR, M., ALP, İ., TEMİZKAN, V., SELÇUK, A., YEDEKÇİ, E., YILMAZ, A. T. (2018). Hybrid Treatment of Supravalvular Aortic Stenosis and Coronary Ostial Stenosis in Familial Hypercholesterolemia. E Journal of Cardiovascular Medicine, Cilt: 6 - Sayı: 2, 68–71. https://ajindex.com/articles/154334

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (8)

  1. Kawasuji M, Sakakibara N, Takemura H, Matsumoto Y, Mabuchi H, Watanabe Y. Coronary artery bypass grafting in familial hypercholesterolemia. J Thorac Cardiovasc Surg. 1995;109:364-369
  2. Qaiser S, Sheikh S, Malik MS. Homozygous Familial Hypercholestrolaemia presents with supravalvular aortic stenosis, J Pak Med Assoc. 2012;62:612-614
  3. Srimannarayana I, Varma RS, Satheesh S, Anilkumar R, Balachander J. Supravalvular Aortic Stenosis and Coronary Ostial Stenosis in Homozygous Familial Hypercholesterolemia. Indian Heart J. 2004;56:152–154
  4. Rallidis L, Naoumova RP, Thompson GR, Nihoyannopoulos P. Extent and severity of atherosclerotic involvement of the aortic valve and root in familial hypercholesterolaemia. Heart. 1998;80:583–590
  5. Beppu S, Minura Y, Sakakibara H, Nagata S, Park YD, Nambu S, Yamamoto A. Supravalvular aortic stenosis and coronary ostial stenosis in familial hypercholesterolemia: two-dimensional echocardiographic assessment. Circulation. 1983;67:878-884
  6. Nemati MH, Astaneh B, Joubeh A. Triple coronary artery bypass graft in a 10-year-old child with familial hypercholesterolemia. Gen Thorac Cardiovasc Surg 2009 57:94–97
  7. Malyshev M, Gladyshev I, Safuanov A, Siniukov D, Borovikov D, Rostovykh N. Surgical angioplasty of the left main coronary artery and/or proximal segment of the right coronary artery by pulmonary autograft patch. Eur J Cardiothorac Surg. 2004;25:21–25
  8. Verhaegh AJ, Accord RE, van Garsse L, Maessen JG. Hybrid coronary revascularization as a safe, feasible, and viable alternative to conventional coronary artery bypass grafting: What is the current evidence? Minim Invasive Surg. 2013;142616.